Effects of frequent and sustained plateletapheresis on peripheral blood mononuclear cell populations and lymphocyte functions of normal volunteer donors

Per procedure, plateletapheresis may remove 2×109 to 3×109 white cells from the peripheral blood of a normal donor. To investigate the effects of frequent and sustained plateletapheresis, multiple peripheral blood tests were performed on 25 volunteer donors undergoing plateletapheresis an average of 72 times over periods of up to 8 years, and results were compared with 25 age‐ and sex‐matched controls who had not undergone apheresis. In donors, significant decreases were observed in: 1) both absolute number and percentage of T4+ cells; 2) absolute number of both T8+ cells and LeU‐7+ cells; 3) T4/T8 ratio; 4) responses to both pokeweed mitogen and alloantigens; and 5) IgG levels. Significant increases were observed in percentages of both B cells and monocytes, and responses to both phytohemagglutinin and Concanavalin A. Plateletapheresis removes a large number of T4 and T8 cells, a moderate number of B cells, and a smaller number of monocytes and Leu‐7 cells. The results suggest that during vigorous plateletapheresis the replenishment to peripheral blood per month was less than 1.83×109 and 0.93×109 for T4 cells and T8 cells, respectively, greater than 0.27×109 and 0.62×109 for B cells and monocytes, respectively, and approximately 0.39×109 for Leu‐7 cells. Although no clinical effect was noted, these data suggest that frequent and sustained non‐lymphocyte sparing plateletapheresis is associated with changes in laboratory findings related to the immune system.

[1]  D. Staunton,et al.  Comparison of MHC antigen expression on PHA- and MLC-induced T cell lines with that on T and B lymphoblastoid cell lines by cell cycle dependency. , 1986, Human immunology.

[2]  S. Krane,et al.  Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. , 1983, Journal of immunology.

[3]  P. Horan,et al.  Long‐Term Follow‐Up of Donors Cytapheresed More Than 50 Times , 1983, Vox sanguinis.

[4]  R. Warnke,et al.  Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. , 1983, Journal of immunology.

[5]  D. Kenney,et al.  The surge technique: a method to increase purity of platelet concentrates obtained by centrifugal apheresis , 1983, Transfusion.

[6]  C. Schiffer,et al.  Collection of platelets depleted of red and white cells with the “surge pump” adaptation of a blood cell separator , 1983, Transfusion.

[7]  R. Aster,et al.  Description and use of the CS‐3000 blood cell separator for single‐donor platelet collection , 1983, Transfusion.

[8]  C. Balch,et al.  Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life , 1983, The Journal of experimental medicine.

[9]  R. Winchester,et al.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. , 1983, Journal of immunology.

[10]  H. Ozer,et al.  Effects of Source Leukocyte Collection on the Immune System , 1982, Vox sanguinis.

[11]  J. Neff,et al.  Immune system changes in cytapheresis donors , 1982, Transfusion.

[12]  R. Aster,et al.  Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. , 1982, Blood.

[13]  B. Löwenberg,et al.  DELAYED ALLOIMMUNISATION BY RANDOM SINGLE DONOR PLATELET TRANSFUSIONS A Randomised Study to Compare Single Donor and Multiple Donor Platelet Transfusions in Cancer Patients with Severe Thrombocytopenia , 1981, The Lancet.

[14]  T. Waldmann,et al.  Human B cell activation in vitro: augmentation and suppression by monocytes of the immunoglobulin production induced by various B cell stimulants. , 1981, Journal of immunology.

[15]  R. Strauss,et al.  The safety of weekly plateletpheresis: effect on the donors' lymphocyte population , 1981, Transfusion.

[16]  L. Nadler,et al.  Characterization of a human B lymphocyte-specific antigen. , 1980, Journal of immunology.

[17]  R. Hoffman,et al.  Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Y. Wang,et al.  Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells , 1980, The Journal of experimental medicine.

[19]  Ellis L. Reinherz,et al.  The differentiation and function of human T lymphocytes , 1980, Cell.

[20]  C. Abboud,et al.  Quantification of Erythroid and Granulocytic Precursor Cells in Plateletpheresis Residues , 1980, Transfusion.

[21]  E. Reinherz,et al.  Further characterization of the human inducer T cell subset defined by monoclonal antibody. , 1979, Journal of immunology.

[22]  W. Knapp,et al.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro. , 1978, Journal of immunology.

[23]  B. Bradley,et al.  Cellular typing. , 1978, British Medical Bulletin.

[24]  J. Macpherson,et al.  Plateletpheresis Using the Haemonetics Model 30 Cell Separator , 1977, Vox sanguinis.

[25]  J. Macpherson,et al.  Plateletpheresis Residues: A Source of Large Quantities of Human Blood Lymphocytes , 2003, Transfusion.

[26]  R. Graw,et al.  Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients. , 1974, Annals of internal medicine.

[27]  F. Grumet,et al.  Platelet transfusion therapy; the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. , 1969, The New England journal of medicine.